Introduction of methanesulfonyl group at 1 1-hydroxyl group (17a) increased both in vitro activity (IC50= 19nM) and in vivo efficacy (ED50= 10mg/kg).
The enzyme acyl-CoA : cholesterol O-acyltransferase (ACAT) [EC 2.3. '5) . Recently, search for ACATinhibitors from microbial origin is one of the growing areas5). However, inhibitory activity of most naturally occurring ACAT inhibitors6~16) was less potent than that of synthetic inhibitors.
Recently, we have isolated pyripyropenes from the fermentation broth of Aspergillus fumigatus FO-1289 as potent ACAT inhibitor17~19). The IC50 value of pyripyropene A (1) is 89 nM, which represents the most potent naturally occurring ACATinhibitor. Importantly, 1 proved to be orally active in hamsters with reducing cholesterol absorption. Therefore, they are expected as excellent lead compounds. The structure of pyripyropenes consists of pyridine, 2-pyrone and terpene moieties, which are categorized to the meroterpenoid20).
Only a few structurally related natural compoundswere reported8'21~23). Wedetermined the absolute stereochemistry of 1 by NOEdifference studies, X-ray crystallographic analysis and Mosher 's NMRmethod24) and clarified the biosynthesis of 1 by feeding experiments using [13C] and [14C] precursors25). Wealso accomplished the first total synthesis of 126).
In this paper, we describe the chemical modification and structure-activity relationships of these four hydroxyl moieties of I27'28). Scheme 1. THE JOURNAL OF ANTIBIOTICS NOV. 1996 Scheme 2.
Chemistry
First, 1 was treated with ammonia gas by bubbling into the methanol to obtain trideacetyl pyripyropene A (2) in a quantitative yield, subsequent acylation of 1-, 7-and ll-hydroxyl groups were carried out by acid anhydride and 4-dimethylaminopyridine (DMAP) in pyridine to give 3 (Scheme 1). 13-hydroxyl group was not acylated under this condition because of the structure hindrance. Selective substitution of 1-, 7-, ll-and 13-hydroxyl groups was carried out as shown in Scheme 2. The primary alcohol at C-l 1 on 2 was selectively acylated by controlling the amount of the reagents. Then, the mono-acylated derivative 4 was acetylated with acetic anhydride, triethylamine, and DMAP in dichloromethane to give the mixture of 5 and 6 by 1, 3-acyl migration, which was separated by HPLCto obtain pure were obtained by two steps. First, selective removal of the 7-Oacetyl group of 1 was accomplished by treatment with 1,8- diazabicyclo [5.4 .0]undec-7-ene (DBU)29) in methanol, and the resultant 7-hydroxyl group of 7 was acylated to give 8. Introduction of an acyl group to the 13-hydroxyl group required an excess amount of reagent and long reaction time to obtain9. Introducinga branchedacyl group such as z-butyryl to the 13-hydroxyl groupwas notsuccessful. Further chemical modification of 7-hydroxylgroup was accomplished as Scheme 3. Acylation of7was carried out by treatment with the correspondingacyl anhydride (MethodA)or acyl chloride(MethodB) in thepresence of triethylamine and DMAP in dichloromethane, or by treatment with correspondingcarboxylic acid, 1,3-dicyclohexylcarbodiimide (DCC), and DMAP in dichloromethane (MethodC) to obtain 8e~8r. Reaction condition of compound 8a to 8r areshown in Table1.
Introduction of thiocarbonylimidazole group (10) to the7-hydroxylgroup of 7 followed by treatment with tributyltinhydride (Bu3SnH) afforded7-dehydroxyl compound (ll). 7-0-Tetrahydropyranyl(THP) derivative (12) was obtained by treatment of 7 with dihydropyrane (DHP) and pyridine-hydrochloride salt in dichloromethane. The 7-O-alkyl derivative (13) was prepared as following; the pyridinemoiety of 1 was first protected as iV-oxide by oxidation with m-chloroperbenzoicacid (m-CPBA).Then,the 7-hydroxyl group was alkylated by treatment with benzyl chlorideand sodium hydride in Scheme 3. dimethylformamide. Finally, TV-oxide was reduced by irradiation in the presence of triethylphosphite30) to give 1700, 1580 :: Solvent of compound 2 is CD3OD; **: IR (KBr) cm" Tables 8 to 12 . The importance of the three acetyl groups of 1 was demonstrated since 2, which has no acetyl groups, lost the inhibitory activity completely (Table 8) . Tri-Opropionyl (3a) showed 10 times less potent inhibitory activity than 1. Other tri-acyl derivatives with w-butyryl (3b), rc-valeryl (3c) or /-butyryl (3d) groups also showed weak activity. Substitution of the three hydroxyl groups with bigger acyl groups did not improve the activity. Next, each of these three acetyl groups was substituted separately with other acyl groups, and the 13-hydroxyl group was modified with an acyl group ( Table 9) .
Substitution with a longer acyl group at the 1 1-hydroxyl group (5a~5d) or introduction of acyl group to the 13-hydroxyl group (9a~9d) significantly reduced the activity, except 5a. The substituent of the ll-position should be a small group. And the free 13-hydroxyl group might be very important for inhibitory activity. As for 1-substituted derivatives propionyl (6a), /-butyryl (6b) or ft-butyryl (6d) analogs showed similar inhibitory activity although w-valeryl analog (6c) weakened the activity. Interestingly, substitution by a longer acyl group at the 7-hydroxyl group appeared to improve the inhibitory activity (1 vs. 8a~8c, Tables 8 and 9 ). The seven fold increase in the activity of 8c in comparison with that of 1 led us to study further modification of 7-substituted derivatives (Table 10) . As for derivatives substituting a linear acyl group (8a~8c and 8e~8g) for the 7-position, longer acyl derivatives with 1-to 5-carbon length showed potent inhibitory activity, and derivatives with more than 6 carbon length decreased the inhibitory activity. As the result, «-valeryl derivative (8c) showed the most potent inhibitory activity among this series of derivatives.
Branched acyl analogs (8d, 8h and 8i) were less potent than the corresponding linear acyl analogs (8a, 8b and 8c, respectively).
Derivatives with a terminal alkene (8k), non-terminal trans-alkoriQ (8j), and terminal alkyne (8n) group at the 7-hydroxyl group showed potent inhibitory activity, but derivatives with a non-terminal alkyne (81 and 8m) groups were less potent. Benzoyl (8o) and thiocarbonyl imidazole (10) analogs showed potent activity, but /?-azidobenzoyl (8p) and nicotinoyl (8q) analogs were less potent. And phenylpropionyl ester (8r) showed potent inhibitory activity. These results indicated that at the fi~5 positions of the acyl chain, structurally similar substituents as normal chain alkane, such as 8j and 8k showed potent inhibitory activity. In contrast, compounds containing branched chain (8d, 8h) or fixed structure which is different to alkane (81 and 8m) at these positions were less active. However, the terminal position can be different structure as alkyne or branched chain (8i, 8n and 8r).
Furthermore, the benzoyl derivative (80) Table ll . Methanesulfonyl analog (17a) showed 5 times more potent inhibitory activity than 1. But derivatives with a longer alkyl chain (17c and 17d) decreased the inhibitory activity dramatically.
As shown in Table 12 , derivatives lacking the free 13-hydroxyl group decreased inhibitory activity. This result suggested that the 13-hydroxyl group is essential for potent ACATinhibitory activity. The in vivo efficacy of 8c and 17a was tested with a hamster model17'28).
The cholesterol absorption was inhibited 57+9% by 8c at 67mg/kg dose, which was almost the same inhibitory activity as 1. Remarkably, 17a showed dose-dependent inhibition with an ED50 value of about lOmg/kg, showing that 17a is ten-fold more potent than 1. Table 9 . Structure and in vitro ACATinhibitory activity of 1,7,1 1,13-0-acylated derivatives. 
Conclusion
Wehave investigated the chemical modification at the 1-, 7-, ll-and 13-hydroxyl groups of pyripyropenes, novel ACATinhibitors. Clear structure-activity relationships of this series of derivatives has been shown as follows: 1) A substituent at the 7-position was essential for potent activity, that is, a) hydrophobicity was desirable, b) the best length was as long as w-valeryl, c) carbonyl moiety at the /? position of the chain was necessary, d) structure at the,/?~<5 position should be similar to straight-chain alkane, and e) alkane carbon at a-atom ofcarbonyl was better than O or NH. 2) Acetyl group at the 1-position showed better activity than other acyl groups, but difference of acyl did not critically relate to the activity. 3) A small substituent such as acetyl or mesyl groups at the 1 1-position was important for potent inhibitory activity. 4) Free hydroxyl group at the 13-position is essential for potent activity. Thus, several derivatives were found as more potent ACATinhibitors than 1. Especially, and l l-<9-methanesulfonyl (17a) derivatives showed significant in vitro ACATinhibition with IC50 values of 13 and 19 nM, respectively.
Furthermore, 17a showed in vivo efficacy in inhibiting cholesterol absorption in cholesterol-fed hamsters (ED50: lOmg/kg, more than 10-fold potent than pyripyropene A).
Experimental
Reagents were obtained from commerical suppliers and were used without purification, unless otherwise noted. Column chromatography was carried out on sillica gel (Merck, Kieselgel 60, Trideacetyl Pyripyropene A (2) 1 (250mg) was dissolved in MeOH (10ml) and ammoniagas was bubbled into the solution at room temperature for 4 days. The reaction mixture was cooled with ice-water bath. The precipitate was washed with cooled MeOHand dried in vacuo to give 2 (154.9mg, 79%) as colorless powder.
General Method of 1,7,1 l-/n-(9-Acylation
To the solution of2 (6.6mg) in dry THF (0.6ml) was added propyonic anhydride (10/il), Et3N (14/il) and DMAP (2mg) , and stirred at room temperature for 6
hours. The reaction mixture was dried up in vacuo and diluted with CH2C12. The organic layer was washed with water and dried over anhrdr sodium sulfide (Na2SO4), then filtered off. The filtrate was concentrated in vacuo and the residue was purified by PTLC (10x20cm, 0,25mm thick, CH2C12:MeOH=10: 1) to afford 3a (3.5mg, 39%) as colorless solid.
In the similar manner, 2 was treated with rc-butiric anhydride, w-valeric anhydride and /-butiric anhydride individually to afford 3b, 3c and 3d (10, 8 and 15%, respectively) .
General Method of l l-mono-O-Acylation Trideacetyl-1 1 -O-propyonyl Pyripyropene A (4a): To the solution of2 (19mg) in dry pyridine (1 ml) was added propyonic anhydride (40^1) and DMAP (2mg), and stirred at room temperature. The reaction mixture was concentrated in vacuo, and the residue was purified by column chromatography (i.d. I x l5cm, CH2C12: MeOH=20: l) to obtain 4a (7mg, 33%) as colorless powder.
In a similar manner, 2 was treated with «-butiric anhydride, w-valeric anhydride and /-butiric anhydride individually to afford 4b, 4c and 4d (61, 43 and 19%, NOV. 1996 respectively).
General Method DMAP(2mg) , and stirred at room temperature for 20
hours. The reaction mixture was washedwith water and dried over anhrdr Na2SO4, then filtered off. The filtrate was concentrated in vacuo to give a mixture of 5a and 6a, which was separated by HPLC(column: SenshuPak ODS-4251-N, eluant: 40% acetonitril-water) to obtain 5a (2.3mg, 28%) and 6a (1.2mg, 15%), respectively. In the similar manner, 4b, 4c and 4d were acetylated individually to afford 5b and 6b (60 and 7%), 5c and 6c (39 and 24%), and 5d and 6d (44 and 29%), respectively.
7-Deacetyl Pyripyropene A (7) Compound 1 (291mg) was hydrolyzed with DBU (75jul) in 80% MeOHaq (10ml). After stirred at room temperature for 10 minutes, the reaction mixture was added AcOH (0.1 ml) and EtOAc (5 ml Et3N (20 fil) were added at 4th and 6th days respectively, and the reaction mixture was heated to 80°C for 1 hour.
After stirring for 14 hours at room temperature, the mixture was cooled to O°Cand additional amount of DMAP(2mg) was added and stirred at 0°C for 2 hours, then MeOH(1 ml) was added and dried up. The residue was diluted with EtOAc (2ml) and washed with water (1 ml x 3), satd NaCl, respectively. The organic phase was dried over anhrdr Na2SO4 then filtered off. The filtrate was concentrated in vacuo to give pale yellow oil, which was purified by PTLC (10x20cm, 0.25mm thick, CH2C12:MeOH=20: 1) to give 8a (4mg, 40%).
Method B : Acyl Chloride 7-0-Hydroxycinnanmoil Pyripyropene A (8r):
To the solution of7 (ll mg) in dry CH2C12(2ml) was added hydrocinnamoyl chloride (4jA) and Et3N (8 /d) , and stirred at room temperature for 15 hours. The reaction mixture was added additional amount of hydrocinnamoyl chloride (6, 15, 15 and 20/J portions) and DMAP(1 mg), during 4 days. The reaction mixture was worked up in a similar manner to 6a and purified VOL.49 NO. ll by PTLC to give 8r (2.5mg, 18%).
Method C : Carboxylic Acid
To the solution of7 (16mg) in dry CH2C12 (1 ml) was added /-caproic acid (4/xl), DCC (10mg) and DMAP (1.2mg) , and stirred at room temperature for 20 hours. Additional amount of DCC(6 mg) was added and stirred for 6 hours, then dried up. The residue was dissolved in cooled EtOAc, and the insoluble residue was filtered off and was washed with cooled EtOAc. The filtrate and the washing were combined and washed with water, satd NaCl respectively, then dried over anhrdr Na2SO4and filtered off. The filtrate was purified by column chroma- to obtain 3-pentynoic acid (393 mg, 31%) as colorless oil.
General Method of 13-O-Acylation 1 3-OAcetyl Pyripyropene A (9a): To the solution of 1 (5mg) in dry THF (0.1ml) was added Ac2O (14/d), Et3N (14/d) and DMAP(4mg), and stirred at room temperature for 17 hours. The reaction mixture was treated in a similar mannerto 3a to give 9a (4mg, 74%).
In the similar manner, 1 was treated with propionic anhydride,^-butyric anhydride and n-valeric anhydride individually to afford 9b, 9c and 9d (56, 93 and 92%, respectively).
7-O-Thiocarbonylimidazoyl
Pyripyropene A (10) A mixture of 7 (16mg) and thiocarbomate (5mg) in dry THF (2 ml) was refluxed at 80°C for 3 hours. Toluene (1 ml) was added to the reaction mixture and was refluxed at 120°C for 1 hour. The reactionwas quenched by adding water and extracted with EtOAc. The organic layer was treated in a similar manner to 8a to give 10 (13.3mg, 69%).
7-Dehydroxyl Pyripyropene A (ll)
To the solution of Bu3SnH(5 /d) in toluene (1 ml) was added 10 (7.5mg in lml toluene) during 2 minutes at 120°C, and stirred for 3 hours/The reaction mixture was concentrated in vacuo to give pale yellow solid, which was purified by PTLC (10x20cm, 0,25mm thick, CH2Cl2:MeOH=10:l) to give ll (lmg, 17%). as colorless powder.
7-0-Tetrahydropyranyl
Pyripyropene A (12) To the solution of7 (9mg) in dry CH2C12 (1 ml) was 1145 added DHP(50 /A) and pyridinium hydrochloride (5 mg) , and stirred at room temperature for 2 days. The reaction mixture was treated in a similar mannerto compound 8r to give 12 (9.2mg, 89%).
7-O-Benzyl Pyripyropene A (13)
To the solution of 7 (80mg) in dry CH2C12 (5ml) was added m-CPBA (40mg).
After stirring at room temperature for 3 hours, the reaction mixture was washed with satd Na2S2O4 and water, respectively. The organic phase was purified in the similar manner as compound 3a to give 7-deacetyl pyripyropene A-7V-oxide (82mg, 100% General Method of 7-OAlkylsunfonylation 7-0-Methanesulfonyl Pyripyropene A (14a): To the solution of 7 (32mg) in dry pyridine (0.6ml) was added methanesulfonyl chloride (7 /il) , and stirred at 0°C for 1 hour and the bath was removed and stirred at room temperature for 1 hour. The reaction mixture was diluted with CH2C12 and the organic layer was treated in the similar manner to 3a to give 14a (21.3mg, 58%).
In the similar manner to 14a, 7 was treated with benzenesulfonyl chloride to give 14b (42%).
General Method of 1-0-Alkylcarbamateion 7-0-Propylcarbamate Pyripyropene A (15a):
To the solution of 7 (10.8mg) in dry CH2C12 (0.2ml) was added propyl isocyanate (2.4/il) and Et3N (4.0jA) , and stirred at roomtemperature. Reaction mixture was quenched by adding satd ammonium chloride and extracted with chloroform. The organic layer was treated in the similar manner to compound 3a to give 15a (4.2 mg, 34%).
In the similar manner to 15a, 7 was treated with^-butyl isocyanate and benzyl isocyanate individually to afford 15b and 15c (24 and 25%, respectively).
7-O-Benzocarbonate Pyripyropene A (15d)
To the solution of7 (10.8mg) in dry CH2C12 (0.2ml) was added carbobenzyl chloride (14.8mg) and Et3N
(4^1), and stirred at room temperature for 20 hours. An additional amount ofcarbobenzyl chloride (14.8 mg) and Et3N (4^1) was added 2 times, at 20 hours and 48 hours, respectively. The reaction mixture was treated in the similar manner to 15a to give 15d (8.5mg, 63%).
7-Keto Pyripyropene A (16)
To the solution of 7 (47mg) in acetone (2ml) was added Jones reagent (40fi\), and stirred at room temperature for 6 hours. The precipitated chloride was filtered off and the filtrate was washed with acetone. The filtrate and washing were combined and dried up. Residue was treated in the similar manner to 3a to give 16 (16.8mg, 36%).
General Method of l l-O-Alkylsulfonylation 1 1-O-Methanesulfonyl Pyripyropene A (17a): To the solution of 2 (158 mg) in dry pyridine (2ml) was added methanesulfonyl chloride (60 /^1), and stirred at 0°C for 30 minutes. The reaction mixture was charged on the ODScolumn chromatography (i.d. 1.5 x 23 cm), and eluted with 20-50% MeOH-water to give tri- To the solution of 1 (64mg) in acetone (40ml) and water (2 ml) was added Jones reagent (0.5 ml), and stirred at room temperature for 3 hours. The reaction mixture was quenched with 2-propanol (0.5ml), and the precipitate was filtered off. The filtrate was dried up and diluted with EtOAc, and washed with water for 2 times, satd Na2SO4,respectively. The organic layer was treated in the similar method to 3a to give 18 (64mg, 100%).
5-Olefin Pyripyropene A (19)
To the solution of 1 (10mg) in dry benzene (0.1ml) was added TFA (1^1), and stirred at room temperature for 4 hours. The reaction mixture was treated in the similar method to 3a to give 19 (7mg, 72%).
Pyripyropene A-7V-Oxide (20) To the solution of1 (58mg) in dry CH2C12 (1 ml) was added m-CPBA(30 mg), and stirred at room temperature for 3 hours. The reaction mixture was treated in a similar manner to 8r to give 20 (53mg, 89%).
3-O-Methyl Pyripyropene A (21)
To the solution of20 (29mg) in dry DMF(1 ml) was added NaH (4mg) and methyl iodide (50 /d), and stirred at 0°C for 10 minutes and at room temperature for 4
